Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VCNX | Common Stock | Options Exercise | $218K | +38.6K | +27.95% | $5.64 | 177K | Sep 18, 2024 | By Vaccinex (Rochester), L.L.C. | F2, F3 |
transaction | VCNX | Common Stock | Options Exercise | $167K | +29.6K | +16.72% | $5.64 | 206K | Sep 18, 2024 | By Vaccinex (Rochester), L.L.C. | F2, F4 |
transaction | VCNX | Common Stock | Options Exercise | $55.1K | +9.77K | +4.73% | $5.64 | 216K | Sep 18, 2024 | By Vaccinex (Rochester), L.L.C. | F2, F5 |
transaction | VCNX | Common Stock | Options Exercise | $201K | +35.7K | +16.53% | $5.64 | 252K | Sep 18, 2024 | By Vaccinex (Rochester), L.L.C. | F2, F4 |
holding | VCNX | Common Stock | 1.58K | Sep 18, 2024 | Direct | ||||||
holding | VCNX | Common Stock | 1.02K | Sep 18, 2024 | By Jeremy C. Zauderer Trust | F1 | |||||
holding | VCNX | Common Stock | 1.01K | Sep 18, 2024 | By Jordan M. Zauderer Trust | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VCNX | Warrant (Right to Buy) | Options Exercise | $0 | -38.6K | -100% | $0.00 | 0 | Sep 18, 2024 | Common Stock | 38.6K | $5.64 | By Vaccinex (Rochester), L.L.C. | F2, F3 |
transaction | VCNX | Warrant (Right to Buy) | Options Exercise | $0 | -29.6K | -100% | $0.00 | 0 | Sep 18, 2024 | Common Stock | 29.6K | $5.64 | By Vaccinex (Rochester), L.L.C. | F2, F4 |
transaction | VCNX | Warrant (Right to Buy) | Options Exercise | $0 | -9.77K | -100% | $0.00 | 0 | Sep 18, 2024 | Common Stock | 9.77K | $5.64 | By Vaccinex (Rochester), L.L.C. | F2, F5 |
transaction | VCNX | Warrant (Right to Buy) | Options Exercise | $0 | -35.7K | -100% | $0.00 | 0 | Sep 18, 2024 | Common Stock | 35.7K | $5.64 | By Vaccinex (Rochester), L.L.C. | F2, F4 |
transaction | VCNX | Warrant (Right to Buy) | Award | $21.3K | +170K | $0.13 | 170K | Sep 18, 2024 | Common Stock | 170K | $5.64 | By Vaccinex (Rochester), L.L.C. | F2 | |
holding | VCNX | Stock Option (Right to Buy) | 12 | Sep 18, 2024 | Common Stock | 12 | $3,129.00 | Direct | F6 | |||||
holding | VCNX | Stock Option (Right to Buy) | 12 | Sep 18, 2024 | Common Stock | 12 | $3,129.00 | Direct | F6 | |||||
holding | VCNX | Stock Option (Right to Buy) | 15 | Sep 18, 2024 | Common Stock | 15 | $1,491.00 | Direct | F6 | |||||
holding | VCNX | Stock Option (Right to Buy) | 135 | Sep 18, 2024 | Common Stock | 135 | $1,402.80 | Direct | F6 | |||||
holding | VCNX | Stock Option (Right to Buy) | 66 | Sep 18, 2024 | Common Stock | 66 | $615.30 | Direct | F7 | |||||
holding | VCNX | Stock Option (Right to Buy) | 133 | Sep 18, 2024 | Common Stock | 133 | $270.90 | Direct | F8 | |||||
holding | VCNX | Stock Option (Right to Buy) | 266 | Sep 18, 2024 | Common Stock | 266 | $92.26 | Direct | F9 | |||||
holding | VCNX | Stock Option (Right to Buy) | 1.88K | Sep 18, 2024 | Common Stock | 1.88K | $8.21 | Direct | F10 |
Id | Content |
---|---|
F1 | Dr. Zauderer exercises voting control over shares held by this trust and disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein. |
F2 | Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |
F3 | This warrant was originally reported on Form 4 with an exercise price of $7.64. Pursuant to a warrant inducement agreement by and between the issuer and Vaccinex (Rochester) L.L.C. dated September 17, 2024 (the "Warrant Inducement Agreement"), the exercise price of this warrant was adjusted to $5.636. |
F4 | This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636. |
F5 | This warrant was originally reported on Form 4 with an exercise price of $32.76. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636. |
F6 | Exercisable in full as of the date of this report. |
F7 | This option vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date, except as otherwise provided in the award notice. |
F8 | This option vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date, except as otherwise provided in the award notice. |
F9 | This option vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date, except as otherwise provided in the award notice. |
F10 | This option vests one-fourth on each of the first four anniversaries of the March 21, 2024 grant date, except as otherwise provided in the award notice. |